These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 11118373)

  • 21. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
    Aiuti F; Mezzaroma I
    AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function.
    Kottilil S; Chun TW; Moir S; Liu S; McLaughlin M; Hallahan CW; Maldarelli F; Corey L; Fauci AS
    J Infect Dis; 2003 Apr; 187(7):1038-45. PubMed ID: 12660917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus permissively infects human syncytiotrophoblasts in vitro and induces replication of human T cell leukemia-lymphoma virus type I in dually infected cells.
    Tóth FD; Aboagye-Mathiesen G; Nemes J; Liu X; Andirkó I; Hager H; Zdravkovic M; Szabó J; Kiss J; Aranyosi J; Ebbesen P
    Virology; 1997 Mar; 229(2):400-14. PubMed ID: 9126252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.
    Chun TW; Davey RT; Ostrowski M; Shawn Justement J; Engel D; Mullins JI; Fauci AS
    Nat Med; 2000 Jul; 6(7):757-61. PubMed ID: 10888923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD8+ anti-human immunodeficiency virus suppressor activity (CASA) in response to antiretroviral therapy: loss of CASA is associated with loss of viremia.
    Wilkinson J; Zaunders JJ; Carr A; Cooper DA
    J Infect Dis; 1999 Jul; 180(1):68-75. PubMed ID: 10353863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection.
    Eggena MP; Barugahare B; Okello M; Mutyala S; Jones N; Ma Y; Kityo C; Mugyenyi P; Cao H
    J Infect Dis; 2005 Mar; 191(5):694-701. PubMed ID: 15688282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection.
    Lacabaratz-Porret C; Urrutia A; Doisne JM; Goujard C; Deveau C; Dalod M; Meyer L; Rouzioux C; Delfraissy JF; Venet A; Sinet M
    J Infect Dis; 2003 Mar; 187(5):748-57. PubMed ID: 12599048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.
    McNeil AC; Shupert WL; Iyasere CA; Hallahan CW; Mican JA; Davey RT; Connors M
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13878-83. PubMed ID: 11717444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-CD4 cytotoxic T lymphocyte (CTL) activity in HIV+ patients: flow cytometric analysis.
    Yamamura Y; Rodriguez N; Schwartz A; Eylar E; Yano N
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S133-44. PubMed ID: 8574141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: a one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients.
    Almeida M; Cordero M; Almeida J; Orfao A
    Cytometry B Clin Cytom; 2007 Jan; 72(1):22-33. PubMed ID: 17051525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between T cell proliferative responses and plasma viremia during treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy.
    Binley JM; Schiller DS; Ortiz GM; Hurley A; Nixon DF; Markowitz MM; Moore JP
    J Infect Dis; 2000 Apr; 181(4):1249-63. PubMed ID: 10762561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.
    Zhang L; Ramratnam B; Tenner-Racz K; He Y; Vesanen M; Lewin S; Talal A; Racz P; Perelson AS; Korber BT; Markowitz M; Ho DD
    N Engl J Med; 1999 May; 340(21):1605-13. PubMed ID: 10341272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptotic killing of CD4+ T lymphocytes in HIV-1-infected PHA-stimulated PBL cultures is mediated by CD8+ LAK cells.
    Wang L; Klimpel GR; Planas JM; Li H; Cloyd MW
    Virology; 1998 Feb; 241(2):169-80. PubMed ID: 9499792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells.
    De Maria A; Pantaleo G; Schnittman SM; Greenhouse JJ; Baseler M; Orenstein JM; Fauci AS
    J Immunol; 1991 Apr; 146(7):2220-6. PubMed ID: 1706390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD; Moore B; Cloyd MW
    Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Viral dynamics in the course of HIV-1 infection: pathogenetic features and new therapeutic prospects].
    Marcello A; Giacca M
    Pathologica; 2000 Aug; 92(4):291-3. PubMed ID: 11029891
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of distinct blood lymphocyte populations in human immunodeficiency virus type 1-infected subjects in the absence or presence of effective therapy.
    Derdeyn CA; Kilby JM; Miralles GD; Li LF; Sfakianos G; Saag MS; Hockett RD; Bucy RP
    J Infect Dis; 1999 Dec; 180(6):1851-62. PubMed ID: 10558941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection.
    Blankson JN; Finzi D; Pierson TC; Sabundayo BP; Chadwick K; Margolick JB; Quinn TC; Siliciano RF
    J Infect Dis; 2000 Dec; 182(6):1636-42. PubMed ID: 11069234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.
    Finzi D; Blankson J; Siliciano JD; Margolick JB; Chadwick K; Pierson T; Smith K; Lisziewicz J; Lori F; Flexner C; Quinn TC; Chaisson RE; Rosenberg E; Walker B; Gange S; Gallant J; Siliciano RF
    Nat Med; 1999 May; 5(5):512-7. PubMed ID: 10229227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudotyping of HIV-1 with Human T-Lymphotropic Virus 1 (HTLV-1) Envelope Glycoprotein during HIV-1-HTLV-1 Coinfection Facilitates Direct HIV-1 Infection of Female Genital Epithelial Cells: Implications for Sexual Transmission of HIV-1.
    Tang Y; George AM; Petrechko O; Nouvet FJ; Sweet SD; Tanaka Y; Imbiakha BS; Jiang G; Gao W; Anastos K; Hildreth JEK
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29624497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.